Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

被引:101
作者
Mueller-Mang, Christina [1 ]
Mang, Thomas [1 ]
Pirker, Agnes [3 ]
Klein, Katharina [2 ]
Prchla, Christine [4 ]
Prayer, Daniela [1 ]
机构
[1] Med Univ Vienna, Dept Radiol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria
[3] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria
[4] SMZ Ost Danube Hosp, Dept Pediat, A-1220 Vienna, Austria
关键词
Posterior reversible encephalopathy syndrome; Hypertensive encephalopathy; Eclampsia; MRI; Neurotoxicity; HUMAN-ENDOTHELIAL-CELLS; LEUKOENCEPHALOPATHY SYNDROME; CYCLOSPORINE-A; HYPERTENSIVE ENCEPHALOPATHY; VASOGENIC EDEMA; WEIGHTED IMAGES; DIFFUSION; NEUROTOXICITY; PREECLAMPSIA; PERFUSION;
D O I
10.1007/s00234-009-0504-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity, characterized by typical neurological deficits, distinctive magnetic resonance imaging (MRI) features, and a usually benign clinical course. Although frequently seen in association with hypertensive conditions, many other predisposing factors, notably cytotoxic and immunosuppressant drugs have been associated with PRES. The aim of this study was to determine differences in the MR appearance of PRES according to various risk factors. Thirty consecutive patients with clinical and MRI findings consistent with PRES were included. We identified 24 patients with hypertension-related conditions, including 14 patients with preeclampsia-eclampsia, and six patients without hypertension, in whom PRES was associated with exposition to neurotoxic substances. Lesion distribution, extent of disease, and number of affected brain regions were compared between patients with PRES with and without hypertension, and patients with PRES with and without preeclampsia-eclampsia, respectively. No statistically significant differences in distribution of lesions and extent of disease were observed between patients with PRES with or without hypertension, and patients with or without preeclampsia-eclampsia, respectively. The number of affected brain regions was significantly higher in patients with preeclampsia-eclampsia (p = 0.046), and the basal ganglia region was more frequently involved in these patients (p = 0.066). Apart from a significant higher number of involved brain regions and a tendency for basal ganglia involvement in patients with PRES associated with preeclampsia-eclampsia, the MRI appearance of patients with PRES does not seem to be influenced by predisposing risk factors.
引用
收藏
页码:373 / 383
页数:11
相关论文
共 37 条
[1]   Posterior leukoencephalopathy without severe hypertension - Utility of diffusion-weighted MRI [J].
Ay, H ;
Buonanno, FS ;
Schaefer, PW ;
Le, DA ;
Wang, B ;
Gonzalez, RG ;
Koroshetz, WJ .
NEUROLOGY, 1998, 51 (05) :1369-1376
[2]   Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature [J].
Badros, Ashraf ;
Goloubeva, Olga ;
Dalai, Jay S. ;
Can, Llyas ;
Thompson, Jennifer ;
Rapoport, Aaron P. ;
Heyman, Meyer ;
Akpek, Gorgon ;
Fenton, Robert G. .
CANCER, 2007, 110 (05) :1042-1049
[3]   Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1043-1049
[4]   Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome [J].
Bartynski, W. S. ;
Boardman, J. F. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (03) :447-455
[5]   Distinct imaging patterns and lesoion distribution in posterior reversible encephalopathy syndrome [J].
Bartynski, W. S. ;
Boardman, J. F. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2007, 28 (07) :1320-1327
[6]  
Bartynski WS, 2006, AM J NEURORADIOL, V27, P2179
[7]   THE ACUTE EFFECT OF FK506 AND CYCLOSPORINE ON ENDOTHELIAL-CELL FUNCTION AND RENAL VASCULAR-RESISTANCE [J].
BENIGNI, A ;
MORIGI, M ;
PERICO, N ;
ZOJA, C ;
AMUCHASTEGUI, CS ;
PICCINELLI, A ;
DONADELLI, R ;
REMUZZI, G .
TRANSPLANTATION, 1992, 54 (05) :775-780
[8]  
Brubaker LM, 2005, AM J NEURORADIOL, V26, P825
[9]  
Covarrubias DJ, 2002, AM J NEURORADIOL, V23, P1038
[10]  
Demirtas Ozgur, 2005, Diagn Interv Radiol, V11, P189